CAGNACCI, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 40.790
AS - Asia 25.301
EU - Europa 22.565
SA - Sud America 4.397
AF - Africa 463
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 29
Totale 93.574
Nazione #
US - Stati Uniti d'America 40.347
GB - Regno Unito 9.020
CN - Cina 7.635
SG - Singapore 7.075
HK - Hong Kong 3.835
BR - Brasile 3.411
IT - Italia 2.818
VN - Vietnam 2.666
DE - Germania 2.315
SE - Svezia 1.874
UA - Ucraina 1.838
FI - Finlandia 1.412
KR - Corea 1.030
RU - Federazione Russa 955
TR - Turchia 926
FR - Francia 882
BG - Bulgaria 665
IN - India 439
AR - Argentina 376
BD - Bangladesh 350
ID - Indonesia 256
MX - Messico 187
IQ - Iraq 181
EC - Ecuador 173
NL - Olanda 133
ZA - Sudafrica 130
CA - Canada 129
CO - Colombia 121
PK - Pakistan 108
JP - Giappone 99
ES - Italia 98
AE - Emirati Arabi Uniti 91
VE - Venezuela 90
PL - Polonia 86
MA - Marocco 83
IE - Irlanda 82
CL - Cile 80
PH - Filippine 69
SA - Arabia Saudita 59
MY - Malesia 56
LT - Lituania 54
EG - Egitto 53
PY - Paraguay 53
UZ - Uzbekistan 51
KE - Kenya 50
IR - Iran 46
BE - Belgio 39
TN - Tunisia 39
PE - Perù 36
JO - Giordania 33
UY - Uruguay 33
NP - Nepal 31
KZ - Kazakistan 30
CH - Svizzera 29
TH - Thailandia 29
PT - Portogallo 28
RO - Romania 28
AZ - Azerbaigian 27
DZ - Algeria 26
DO - Repubblica Dominicana 25
JM - Giamaica 25
EU - Europa 24
AU - Australia 23
AL - Albania 22
AT - Austria 21
IL - Israele 20
BO - Bolivia 19
CZ - Repubblica Ceca 18
CR - Costa Rica 17
GR - Grecia 17
DK - Danimarca 16
OM - Oman 16
RS - Serbia 16
BH - Bahrain 15
BY - Bielorussia 15
ET - Etiopia 15
TW - Taiwan 15
KG - Kirghizistan 14
LB - Libano 13
PA - Panama 13
QA - Qatar 13
PS - Palestinian Territory 12
SI - Slovenia 12
GE - Georgia 11
HN - Honduras 11
BA - Bosnia-Erzegovina 10
HR - Croazia 10
HU - Ungheria 9
NG - Nigeria 9
SN - Senegal 9
AM - Armenia 8
CY - Cipro 8
LV - Lettonia 8
NI - Nicaragua 8
TT - Trinidad e Tobago 8
CI - Costa d'Avorio 7
KW - Kuwait 7
LY - Libia 7
SK - Slovacchia (Repubblica Slovacca) 7
NZ - Nuova Zelanda 6
Totale 93.454
Città #
Southend 7.074
Singapore 4.318
Jacksonville 4.031
Santa Clara 3.849
Hong Kong 3.784
Fairfield 3.613
Ashburn 2.783
Dearborn 2.598
Hefei 2.590
Woodbridge 2.280
Chandler 2.083
Houston 1.746
Beijing 1.477
Wilmington 1.472
London 1.397
Ann Arbor 1.232
Seattle 1.230
Cambridge 1.149
Nyköping 1.120
Seoul 981
Ho Chi Minh City 903
The Dalles 869
San Jose 759
Helsinki 758
Princeton 758
Sofia 656
Eugene 640
Hanoi 631
Modena 608
Lauterbourg 553
Los Angeles 551
Dallas 441
Izmir 428
Bremen 423
Chicago 391
Buffalo 380
San Diego 370
New York 311
Council Bluffs 297
São Paulo 296
Shanghai 282
Moscow 243
Milan 208
Des Moines 185
Salt Lake City 147
Rome 125
Guangzhou 124
Haiphong 119
Da Nang 106
Norwalk 105
Rio de Janeiro 99
Frankfurt am Main 88
Jakarta 88
Kunming 87
Orem 82
Dublin 78
Nanjing 77
Tokyo 72
Columbus 70
Tampa 68
Baghdad 67
Belo Horizonte 67
Curitiba 64
Brasília 62
Elk Grove Village 62
Chennai 58
Quito 58
Amsterdam 53
Munich 53
Biên Hòa 51
Johannesburg 51
Guayaquil 50
Hải Dương 50
Mexico City 50
San Mateo 50
Dhaka 49
Tashkent 49
Boardman 47
Bologna 44
Dubai 43
Falls Church 43
Verona 43
Jinan 42
Thái Bình 42
Campinas 41
Falkenstein 41
Manchester 41
Nairobi 41
Redwood City 41
Santiago 40
Warsaw 40
Goiânia 39
Brooklyn 38
Dongguan 38
Lahore 37
Nanchang 37
Changsha 36
Atlanta 35
Bắc Ninh 35
San Francisco 35
Totale 66.146
Nome #
Intensity of menstrual pain and estimated angle of uterine flexion 408
La melatonina aumenta la risposta delle gonadotropine al GnRH nelle donne in fase follicolare precoce, ma non nella fase luteale 406
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 360
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 347
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 335
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 325
Association between urinary incontinence and climacteric symptoms in postmenopausal women 315
Intermenstrual pelvic pain, quality of life and mood 312
Differenza tra forma attiva (5-MTHF) e inattiva (acido folico) di folati sulla vasodilatazione di donne in postmenopausa 310
Adenomyosis of the Extrapelvic Portion of the Round Ligament 308
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 306
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 293
Folate administration decreases oxidative status and blood pressure in postmenopausal women 292
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 292
Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain 289
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 288
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 282
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 280
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 278
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 278
Metabolic impact of combined hormonal contraceptives containing estradiol 277
Recommendations for contraception in women with diabetes. AMD-SIC position paper 276
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 276
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 273
Continuous combined hormone replacement therapy with oral 17β-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women 272
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 272
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 272
Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive. A Patient-Preference Prospective 24-Week Pilot Study 271
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women 270
Pharmacokinetic evaluation of desogestrel as a female contraceptive 266
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 262
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 261
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 260
Melatonin in relation to physiology in adult humans 258
Season of birth influences the timing of menopause 257
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 255
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 253
Medical and patient attitude towards vaginal atrophy: the AGATA study 249
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women 248
A role for melatonin in PCOS? 247
Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. 243
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 243
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. 242
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 242
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 242
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 240
Amplification of pulsatile LH secretion by exogenous melatonin in women. 240
Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease. 240
Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study 239
Prolonged melatonin administration decreases nocturnal blood pressure in women 238
Anello Contraccettivo: i vantaggi della somministrazione vaginale 232
Prevalence of menstrual pain in young women: What is dysmenorrhea? 232
Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study 232
Pharmacological, metabolic and clinical aspects of new oral contraceptive associations containing natural estrogens [Aspetti farmacologici, metabolici e clinici delle nuove associazioni contraccettive a base di estrogeni naturali] 230
Conseguenze dell'Isterectomia associata o no ad ovariectomia nella donna 230
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 229
Efficacia del nomegestrolo acetato, derivato del 19-Nor progesterone, nel trattamento dei sintomi premestruali: uso in casi selezionati con fase luteale inadeguata 229
Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol 228
Role of melatonin in circadian rhythm at menopause 227
Influence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during oestradiol replacement. 227
Hypothermic effect of melatonin and nocturnal core body temperature decline are reduced in aged women. 226
Drospirenone: dati di sicurezza a lungo termine 226
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women 225
Influence of melatonin and photoperiod on animal and human reproduction 224
Seasonal trend of acute pelvic inflammatory disease 223
Contraccettivi con soli progestinici in perimenopausa.Effetti sul dispendio energetico e composizione corporea 222
Amplification of pulsatile LH secretion by exogenous melatonin in women 222
Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women. 221
Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism. 220
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 218
Ovary Cystadenofibroma Associated with Didelphys Uterus in a Teenager: Conservative Laparoscopic Management 217
Melatonin: a major regulator of the circadian rhythm of core temperature in humans. 217
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 217
Correlazione tra i livelli di omocisteina e densità minerale ossea in donne in postmenopausa. Uno studio longitudinale 216
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group* 216
European society of contraception statement on contraception in obese women 216
Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease. 215
Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. 215
Lack of any estrogenic effect of ipriflavone in postmenopausal women. 214
Effetti dell’ HRT e SERM sulla pressione arteriosa 214
Hormone replacement therapy and glucose metabolism 213
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 213
Fattori implicati nel determinismo del sesso del nascituro 212
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 208
Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women. 207
The effect of menopause on blood lipid and lipoprotein levels 207
A comparison of the central effects of different progestins used in hormone replacement therapy 207
Effetto di una terapia ormonale sostitutiva combinata continua contenente noretisterone acetato e del tibolone sulla pressione arteriosa delle 24 h ore 206
Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women 205
Melatonin enhances cortisol levels in aged but not young women. 205
“In patient” medical abortion versus surgical abortion: patient’s satisfaction 205
Nutrition, Nutriceuticals in older women. 204
The effect of tibolone on 24h blood pressure and heart rate 204
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 204
HRT e apparato cardiovascolare 203
Estrogeni e ossido nitrico: un sinergismo. 202
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 202
Oral contraceptive containing drospirenone and 24-hour ambulatory blood pressare. Preliminare data from a prospective study 201
Blood pressure and cardiovascular risk factors in women treated for climacteric symptoms with acupuncture, phytoestrogens, or hormones 201
Anello contraccettivo:sicurezza ed effetti locali 199
Totale 24.776
Categoria #
all - tutte 346.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 346.922


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.657 0 0 0 0 0 0 0 0 0 1.005 356 296
2021/20226.963 130 1.273 483 459 142 334 250 390 941 573 704 1.284
2022/20236.690 972 573 365 449 1.184 1.018 125 616 891 60 225 212
2023/20244.666 201 264 198 332 1.266 515 622 569 74 59 117 449
2024/202515.613 486 186 115 1.142 3.078 2.003 936 720 2.249 1.091 1.169 2.438
2025/202625.938 1.457 1.520 3.988 4.026 2.537 1.818 3.289 1.888 2.599 2.816 0 0
Totale 94.127